share_log

Evelo Biosciences | EFFECT: Others

Evelo Biosciences | EFFECT：其他

美股sec公告 ·  03/11 18:06
牛牛AI助理已提取核心訊息
The United States Securities and Exchange Commission (SEC) has declared a notice of effectiveness for Evelo Biosciences, Inc. The notice, which signifies that a submission by the company has been accepted and is now effective, was dated March 8, 2024. The submission type was POS AM, with an accession number of 0001193125-24-016886. Evelo Biosciences, identified by CIK 0001694665, had filed under the number 333-273869.
The United States Securities and Exchange Commission (SEC) has declared a notice of effectiveness for Evelo Biosciences, Inc. The notice, which signifies that a submission by the company has been accepted and is now effective, was dated March 8, 2024. The submission type was POS AM, with an accession number of 0001193125-24-016886. Evelo Biosciences, identified by CIK 0001694665, had filed under the number 333-273869.
美國證券交易委員會（SEC）宣佈了Evelo Biosciences, Inc.的生效通知。該通知的日期爲2024年3月8日，表明該公司提交的材料已被接受並現已生效。提交類型爲 POS AM，註冊號爲 0001193125-24-016886。由CIK 0001694665確認的Evelo Biosciences已以333-273869的編號提交了申請。
美國證券交易委員會（SEC）宣佈了Evelo Biosciences, Inc.的生效通知。該通知的日期爲2024年3月8日，表明該公司提交的材料已被接受並現已生效。提交類型爲 POS AM，註冊號爲 0001193125-24-016886。由CIK 0001694665確認的Evelo Biosciences已以333-273869的編號提交了申請。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生，只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。